tiprankstipranks
OnKure Therapeutics (OKUR)
NASDAQ:OKUR
US Market
OKUR
OnKure Therapeutics
RESEARCH TOOLSreports
Want to see OKUR full AI Analyst Report?

OnKure Therapeutics (OKUR) Stock News & Sentiment

439 Followers
OnKure Buy Rating Reiterated as Analyst Backs Pipeline Refocus, Strong Cash Position and Maintains $16 Price Target
Premium
Ratings
OnKure Buy Rating Reiterated as Analyst Backs Pipeline Refocus, Strong Cash Position and Maintains $16 Price Target
18d ago
OKUR
OnKure Announces $150M Private Placement and Board Changes
Premium
Company Announcements
OnKure Announces $150M Private Placement and Board Changes
2M ago
8K
OKUR
OnKure Therapeutics: Positive View on OKI-219 Ahead of PIKture-1 Breast Cancer Data as Key Upside Catalyst
Premium
Ratings
OnKure Therapeutics: Positive View on OKI-219 Ahead of PIKture-1 Breast Cancer Data as Key Upside Catalyst
2M ago
OKUR
OnKure Therapeutics Advances Clinical Programs and Expands Focus
Premium
Company Announcements
OnKure Therapeutics Advances Clinical Programs and Expands Focus
6M ago
OKUR
Promising Prospects for OnKure Therapeutics: Buy Rating Backed by OKI-219 Developments and Strategic Expansion
Premium
Ratings
Promising Prospects for OnKure Therapeutics: Buy Rating Backed by OKI-219 Developments and Strategic Expansion
7M ago
OKUR
Strategic Delay and Diversification: OnKure Therapeutics Positioned for Growth with Buy Rating
Premium
Ratings
Strategic Delay and Diversification: OnKure Therapeutics Positioned for Growth with Buy Rating
7M ago
OKUR
OnKure Therapeutics: Strategic Advancements and Promising Clinical Developments Drive Buy Rating
Premium
Ratings
OnKure Therapeutics: Strategic Advancements and Promising Clinical Developments Drive Buy Rating
7M ago
OKUR
More OKUR News >

OKUR News on the Web

OnKure Therapeutics (OKUR) Gets a Buy from JonesTrading
TipRanks News
Neutral
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
OnKure Announces $150M Private Placement and Board Changes
TipRanks News
Neutral
Pre-Market Most Active for Mar 27, 2026 : TQQQ, TSLL, IBIT, OKUR, ETHA, SQQQ, LAR, U, SNAP, NOK, NIO, IONQ
NASDAQ.com
Bullish
OnKure Therapeutics to sell 26.713M shares at $4.15 in private placement
TipRanks News
Bullish
OnKure Therapeutics: Positive View on OKI-219 Ahead of PIKture-1 Breast Cancer Data as Key Upside Catalyst
TipRanks News
Bullish
OnKure Therapeutics price target lowered to $27 from $34 at H.C. Wainwright
TipRanks News
Bearish
Analysts Offer Insights on Healthcare Companies: Nektar Therapeutics (NKTR), OnKure Therapeutics (OKUR) and Purple Biotech (PPBT)
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
OKUR
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.75 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is OKUR’s Media Buzz Sentiment?
1 articles about OKUR were published this week. In an average week, 1.75 articles are published.
    What is OKUR’s weekly average amount of articles?
    In an average week, 1.75 articles about OKUR are published.
      What is OKUR’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      GOSSGossamer Bio
      RLAYRelay Therapeutics
      ROIVRoivant Sciences
      ILAIsland Pharmaceuticals Ltd
      TLSATiziana Life Sciences
      Showing the stocks with the most bullish news sentiment over the past week